Navigation Links
VITROS® Anti-HCV Assay

ProductsVITROS® Anti-HCV Assay
Company Ortho-Clinical Diagnostics
Item VITROS® Anti-HCV Assay
Features 
  • Runs on a fully automated, random access analyzer, so results are available at any time, in any order.
  • Clinically proven to detect for hepatitis C virus in individuals with risk factors associated with HCV infection
  • Provides presumptive evidence in conjunction with other laboratory results and clinical information of individuals infected with hepatitis C virus
  • Description The VITROS Anti-HCV assay is the third diagnostic hepatitis assay approved by the U.S. Food and Drug Administration capable of being run in a random access format on the VITROS ECi Immunodiagnostic System with Intellicheck. Now the laboratory staff can run an anti-HCV test anytime with the complete menu of more than 27 assays, and provide anti-HCV test results in one hour or less.
    Info Ortho-Clinical DiagnosticsCall Ortho-Clinical Diagnostics to buy products (US and Canada only; other locations use number below) USACanada1-866-802-9580

    Customer Service: 1-800-828-6316
    Web site: http://www.orthoclinical.com

    Related medicine products :

    1. VITROS® Anti-HBs Assay
    2. Anti-HCV Test
    3. Anti-HCV Low Titer Performance Panel
    4. Uric Acid Enzymatic Assay
    5. Lithium Enzymatic Assay Kit
    6. Retinol Binding Protein EIA Vitamin Assays 030-6110 RBP Bone and Minearl Metabolism
    7. Vitamin B6 Jumbo REA Vitamin Assays, Cardiovascular 001-RK-VB6N
    8. Vitamin B6 REA Vitamin Assays, Cardiovascular 001-RK-VB6
    9. Procleix HIV-1/HCV Assay
    10. VERSANT HIV RNA 3.0 Assay (bDNA)
    11. Wampole PreVue B. Burgdorferi Antibody Detection Assay
    Full Handle Laseredge Stab Blade Knife, 30 blade. Blade tip dimension: 10.5 mm x 1.9 mm x 3.4 mm....
    19 Gauge. Reusable. Block of 4 each....
    Set consist of two 27 gauge, stainless steel probes with blunt tips. Probes are 11.5 cm (4.5 inches) long with 30.5 cm (12 inches) of flexible tubing (O.D. - 0.60 mm, I.D. - 0.30 mm) attached onto th...
    19 gauge x 8 mm with 15 cm high pressure extension tube preattached to a 10C ring control syringe. 3 per box....
    Medicine Products:
    (Date:4/22/2014)... lung cancer are 70 years of age or older, ... not well represented in clinical trials. Therefore, the paucity ... evidence based clinical recommendations. , In 2010, the EORTC ... Group along with the International Society for Geriatric Oncology ... elderly patients with non-small cell lung cancer (NSCLC), and ...
    (Date:4/22/2014)... to trauma, illness, alcohol or other drug abuse, these ... cells that can go awry and activate conditions such ... autism. , Until now, it has been unclear how ... developing brain. Past studies have shown that when an ... or she experiences some trauma or illness, her baby ...
    (Date:4/22/2014)... (April 22, 2014) Cedars-Sinai stroke intervention researchers have ... and Stroke, part of the National Institutes of Health, ... multicenter Phase II clinical trial of an experimental drug ... used in combination with recombinant tissue plasminogen activator, or ... ischemic strokes shortly after onset. In laboratory rodent studies, ...
    (Date:4/22/2014)... Based on results of a clinical trial ... Food and Drug Administration (FDA) approved a molecularly ... cancer that has progressed after standard chemotherapy has ... review was announced by the manufacturer, Lilly Oncology, ... name ramucirumab, it will be sold under the ...
    (Date:4/22/2014)... of the University of Calgary,s Hotchkiss Brain Institute (HBI) ... cells as a means to restore connections after injury. ... key molecule that directly regulates nerve cell growth in ... the prestigious journal Nature Communications , with lead ... "We made the surprising discovery that a protein called ...
    Breaking Medicine News(10 mins):Health News:EORTC and SIOG update expert opinion on management of elderly patients with NSCLC 2Health News:Life stressors trigger neurological disorders, researchers find 2Health News:$8 million NIH grant will fund multicenter clinical trial of stroke intervention drug 2Health News:$8 million NIH grant will fund multicenter clinical trial of stroke intervention drug 3Health News:FDA approves first targeted drug for advanced stomach cancer 2Health News:Scientists discover a new way to enhance nerve growth following injury 2
    ... BELLEVUE, Wash. and WASHINGTON, Oct. 4 Revolution,Health ... fastest growing health,properties, and drugstore.com (Nasdaq: DSCM ... and pharmacy products, today announced a major,agreement whereby ... the Revolution Health Network and manage advertising sales ...
    ... and Research,s (A*STAR) Institute of Molecular and Cell ... provide a more detailed understanding of how the ... albicans transforms into a serious and often life-threatening ... serious and potentially life-threatening infections in the mouth, ...
    ... FAIRFAX, Va., Oct. 4 SRA International, Inc.,(NYSE: ... and strategic consulting,services and solutions to federal government ... an enterprise-wide infrastructure,architecture for the Department of Justice ... Support Services-3 contract, has an,estimated value of $59 ...
    ... ,Tour to Insure, will Highlight Need to Reduce,Costs, Expand ... G.,Rendell will continue his campaign to reduce the costs ... with the passage of the,remainder of his "Prescription for ... bus tour. The five-day, nine-stop "Tour to Insure",will include ...
    ... operational,clinical and technological innovator in emergency medical services, ... ground, this time in the,way it hires the ... and around,Charlotte, N.C. While the nation,s emergency ... already trained in an academic setting,Medic is hiring ...
    ... Drive for Decision, CHARLESTON, S.C., Oct. 4 ... to introduce a proactive self-funding process to,secure the ... for the domestic shrimping industry. Beginning in January ... combination of federal government,assistance, voluntary industry contributions, foundation ...
    Cached Medicine News:Health News:drugstore.com and Revolution Health Group Announce Breakthrough Deal 2Health News:drugstore.com and Revolution Health Group Announce Breakthrough Deal 3Health News:How Candida albicans transforms from its normally benign form into life-threatening form 2Health News:Department of Justice Awards $59M Task Order to SRA 2Health News:Governor Rendell to Fight to 'Cover All Pennsylvanians' During Statewide Bus Tour 2Health News:Mecklenburg EMS Agency Launches Innovative Program to Pay Future EMT's While They Train 2Health News:Wild American Shrimp Board Agrees To Implement New Self-Funding Measures 2
    (Date:1/15/2014)... , Jan. 15, 2014 ... research report is available in its ... Markets and Technologies for Advanced Drug ... of Administration ...
    (Date:1/14/2014)... Jan. 14, 2014 HeartWare International, Inc . ... less invasive, miniaturized circulatory support technologies that are revolutionizing ... it expects revenues for the fourth quarter of 2013 ... revenues to approximately $208 million. "Our full-year ...
    (Date:1/14/2014)... , Jan. 14, 2014 The Brandeis Medical Center, led by ... a premier and affordable laser tattoo removal experience with the ... focus is in providing high quality cosmetic services with cutting edge ... " Southern California has seen a dramatic ...
    Breaking Medicine Technology:Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 16HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 2HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 4Beverly Hills Physician Features Tattoo Removal with the Astanza Duality Laser, Offers $99 Special 2